What is the primary treatment for a child diagnosed with growth hormone deficiency?

The primary treatment for a child diagnosed with growth hormone deficiency is the administration of somatropin through subcutaneous injections. Somatropin is a synthetic form of growth hormone that mimics the effects of naturally occurring growth hormone in the body. This treatment aims to stimulate growth and development in children who have insufficient amounts of growth hormone, thereby helping them achieve a more typical height and overall growth trajectory.

Subcutaneous injections are the preferred method for delivering somatropin because they allow for consistent and controlled dosing, which is crucial for effective treatment. This method also supports flexibility in administration, often being done at home, which can improve adherence to the treatment regimen.

The effectiveness of somatropin is well-established in managing growth hormone deficiency, helping to boost linear growth in affected children. By providing the necessary hormone that their bodies lack, it aids in achieving a better quality of life and physical development.

While oral medication and growth hormone therapy through infusion may seem like plausible options, they do not align with the standard treatment protocols for this condition. Physical therapy interventions, while potentially beneficial for overall development and addressing other aspects of care, do not address the underlying hormonal deficiency directly.